Ardena Assen, the former Analytisch Biochemisch Laboratorium BV (ABL), at the W.A. Scholtenstraat 7 in Assen is expanding its capacity.
This renowned pharmaceutical research laboratory, which has been located in Assen since 1969, was acquired by the Ardena group in 2017. The Ardena Group, with offices in Assen, Ghent, Oss, Amsterdam, Stockholm and Riga, provides a wide range of pharmaceutical services for the development and registration of new medicines, including synthesis, formulation and regulatory dossier development.
The laboratory on the W.A. Scholtentenstraat is involved in the analysis of experimental medicines in biological materials. This qualified work takes place under strict quality standards, using highly sensitive techniques. In this way, the laboratory contributes to the discovery, development and registration of new medicines.
Because this type of work is more and more outsourced and as a result of the successful synergy within the Ardena group, expansion in Assen is necessary and the current capacity is doubled. Construction will start on Monday 21 October and completion is foreseen for mid-2020. With this expansion, it will be possible to anticipate the growth of the facility in Assen and the Ardena group in general.